Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Disopyramide phosphate 100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 100mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide 100mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide 150mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide 100mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide 100mg capsule (substance) |
Has basis of strength substance (attribute) |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide 150mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide 150mg capsule (substance) |
Has basis of strength substance (attribute) |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide phosphate 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 150mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide phosphate 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral capsule |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide 100mg capsule (substance) |
Has precise active ingredient |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide 150mg capsule (substance) |
Has precise active ingredient |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 50 milligram/5 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide (as disopyramide phosphate) 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide (as disopyramide phosphate) 100 mg oral capsule |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Disopyramide (as disopyramide phosphate) 150 mg oral capsule |
Has precise active ingredient |
True |
Disopyramide phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |